Amplify Weight Loss Drug & Treatment ETF (THNR)
NYSEARCA: THNR · Real-Time Price · USD
24.66
-0.11 (-0.44%)
At close: Mar 6, 2026, 4:00 PM EST
24.66
0.00 (0.00%)
After-hours: Mar 6, 2026, 8:00 PM EST

THNR Holdings List

Mar 4, 2026
No.SymbolName WeightShares
1LLYEli Lilly and Company12.16%519
2NVONovo Nordisk A/S9.45%10,513
3AMGNAmgen Inc.7.85%887
4TYO: 4519Chugai Pharmaceutical Co., Ltd.7.54%5,200
5REGNRegeneron Pharmaceuticals, Inc.6.91%376
6TYO: 4507Shionogi & Co., Ltd.6.14%12,100
7MRKMerck & Co., Inc.5.99%2,132
8SWX: ROGRoche Holding AG5.66%527
9LON: AZNAstraZeneca PLC5.50%1,168
10ABBVAbbVie Inc.5.18%940
11PFEPfizer Inc.5.10%8,199
12HKG: 1801Innovent Biologics, Inc.4.40%19,000
13HKG: 1093CSPC Pharmaceutical Group Limited4.08%152,000
14ARWRArrowhead Pharmaceuticals, Inc.3.90%2,569
15SRRKScholar Rock Holding Corporation1.79%1,615
16CPH: ZEALZealand Pharma A/S1.75%1,295
17VKTXViking Therapeutics, Inc.1.68%2,236
18HIMSHims & Hers Health, Inc.1.60%4,169
19AGPXXShort-Term Investment Trust - Invesco Government & Agency Portfolio1.29%55,213
20KRX: 128940Hanmi Pharm. Co., Ltd.0.93%123
21JNGHFJiangsu Hengrui Pharmaceuticals Co Ltd Ordinary Shares - Class H0.79%4,400
22n/aOTHER ASSETS AND LIABILITIES0.31%153,310,294
As of Mar 4, 2026